101 related articles for article (PubMed ID: 15686482)
21. Aminopeptidase P isozyme expression in human tissues and peripheral blood mononuclear cell fractions.
Erşahin C; Szpaderska AM; Orawski AT; Simmons WH
Arch Biochem Biophys; 2005 Mar; 435(2):303-10. PubMed ID: 15708373
[TBL] [Abstract][Full Text] [Related]
22. [3-Me-His(2)]-TRH combined with dopamine withdrawal rapidly and transiently increases pyroglutamyl aminopeptidase II activity in primary cultures of adenohypophyseal cells.
Bourdais J; Romero F; Uriostegui B; Cisneros M; Joseph-Bravo P; Charli JL
Neuropeptides; 2000 Apr; 34(2):83-8. PubMed ID: 10985924
[TBL] [Abstract][Full Text] [Related]
23. A new transcript splice variant of the human glucocorticoid receptor: identification and tissue distribution of hGR Delta 313-338, an alternative exon 2 transactivation domain isoform.
Turner JD; Schote AB; Keipes M; Muller CP
Ann N Y Acad Sci; 2007 Jan; 1095():334-41. PubMed ID: 17404046
[TBL] [Abstract][Full Text] [Related]
24. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway.
Li TS; Li XN; Chang ZJ; Fu XY; Liu L
Cell Signal; 2006 Aug; 18(8):1287-98. PubMed ID: 16310341
[TBL] [Abstract][Full Text] [Related]
25. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
[TBL] [Abstract][Full Text] [Related]
26. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species.
Jurado J; Fuentes-Almagro CA; Prieto-Alamo MJ; Pueyo C
BMC Mol Biol; 2007 Sep; 8():83. PubMed ID: 17888145
[TBL] [Abstract][Full Text] [Related]
27. A rare mRNA variant of the human lymphocyte-specific protein tyrosine kinase LCK gene with intron B retention and exon 7 skipping encodes a putative protein with altered SH3-dependent molecular interactions.
Nervi S; Guinamard R; Delaval B; Lécine P; Vialettes B; Naquet P; Imbert J
Gene; 2005 Oct; 359():18-25. PubMed ID: 16107303
[TBL] [Abstract][Full Text] [Related]
28. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
Harashima A; Yamamoto Y; Cheng C; Tsuneyama K; Myint KM; Takeuchi A; Yoshimura K; Li H; Watanabe T; Takasawa S; Okamoto H; Yonekura H; Yamamoto H
Biochem J; 2006 May; 396(1):109-15. PubMed ID: 16503878
[TBL] [Abstract][Full Text] [Related]
29. Regulation of adenohypophyseal pyroglutamyl aminopeptidase II activity by thyrotropin-releasing hormone and phorbol esters.
Vargas MA; Cisneros M; Joseph-Bravo P; Charli JL
Endocrine; 2000 Dec; 13(3):267-72. PubMed ID: 11216637
[TBL] [Abstract][Full Text] [Related]
30. Aminopeptidase O contains a functional nucleolar localization signal and is implicated in vascular biology.
Axton R; Wallis JA; Taylor H; Hanks M; Forrester LM
J Cell Biochem; 2008 Mar; 103(4):1171-82. PubMed ID: 17803194
[TBL] [Abstract][Full Text] [Related]
31. Human Sec31B: a family of new mammalian orthologues of yeast Sec31p that associate with the COPII coat.
Stankewich MC; Stabach PR; Morrow JS
J Cell Sci; 2006 Mar; 119(Pt 5):958-69. PubMed ID: 16495487
[TBL] [Abstract][Full Text] [Related]
32. Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms.
Bakker RA; Lozada AF; van Marle A; Shenton FC; Drutel G; Karlstedt K; Hoffmann M; Lintunen M; Yamamoto Y; van Rijn RM; Chazot PL; Panula P; Leurs R
Mol Pharmacol; 2006 Apr; 69(4):1194-206. PubMed ID: 16415177
[TBL] [Abstract][Full Text] [Related]
33. Changes in TRH and its degrading enzyme pyroglutamyl peptidase II, during the development of amygdaloid kindling.
de Gortari P; Fernández-Guardiola A; Martinez A; Cisneros M; Joseph-Bravo P
Brain Res; 1995 May; 679(1):144-50. PubMed ID: 7648256
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the human SLC2A11 (GLUT11) gene: alternative promoter usage, function, expression, and subcellular distribution of three isoforms, and lack of mouse orthologue.
Scheepers A; Schmidt S; Manolescu A; Cheeseman CI; Bell A; Zahn C; Joost HG; Schürmann A
Mol Membr Biol; 2005; 22(4):339-51. PubMed ID: 16154905
[TBL] [Abstract][Full Text] [Related]
35. Subcellular localization of human heparanase and its alternative splice variant in COS-7 cells.
Sato M; Amemiya K; Hayakawa S; Munakata H
Cell Biochem Funct; 2008 Aug; 26(6):676-83. PubMed ID: 18646256
[TBL] [Abstract][Full Text] [Related]
36. Quantitation and regulation of pyroglutamyl peptidase II messenger RNA levels in rat tissues and GH3 cells.
Lin J; Wilk S
Neuroendocrinology; 1998 Mar; 67(3):197-208. PubMed ID: 9630437
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicing variations in mouse CAPS2: differential expression and functional properties of splicing variants.
Sadakata T; Washida M; Furuichi T
BMC Neurosci; 2007 Apr; 8():25. PubMed ID: 17428348
[TBL] [Abstract][Full Text] [Related]
38. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
39. NSSRs/TASRs/SRp38s function as splicing modulators via binding to pre-mRNAs.
Fushimi K; Osumi N; Tsukahara T
Genes Cells; 2005 Jun; 10(6):531-41. PubMed ID: 15938712
[TBL] [Abstract][Full Text] [Related]
40. Regulation of a thyrotropin-releasing hormone-degrading enzyme in GH3 cells: induction of pyroglutamyl peptidase I by 3,5,3'-triiodothyronine.
Suen CS; Wilk S
Endocrinology; 1987 Aug; 121(2):770-5. PubMed ID: 2885183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
